SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community
 
| More

TMCNet:  Implant Sciences Ships Three Additional Quantum Sniffers to Japan for Protection of Nuclear Power Plants

[December 17, 2012]

Implant Sciences Ships Three Additional Quantum Sniffers to Japan for Protection of Nuclear Power Plants

WILMINGTON, MA, Dec 17, 2012 (MARKETWIRE via COMTEX) -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold and shipped three more of its Quantum Sniffer(TM) QS-H150 handheld explosives trace detectors to a current customer in Japan. The units are to be deployed in Japan for the protection of a nuclear power facility. This is a repeat order from the customer and marks the third shipment of QS-H150s to Japan for nuclear power plant protection this quarter.


"The best endorsement we can have for our products is receiving repeat orders from customers around the world. The Japanese nuclear power industry has been one of our most reliable repeat customers, with a purchase history extending back to 2008. We are proud to support the security of this critical Japanese industry," said Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones.

About the Quantum Sniffer(TM) QS-H150 Handheld Explosives Trace Detector The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.

About Implant Sciences Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets.

The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally.

Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact: Implant Sciences Corporation Company Contact: Glenn Bolduc CEO 978-752-1700 Email Contact or Investor Contact: Laurel Moody 646-810-0608 Email Contact SOURCE: Implant Sciences Corporation http://www2.marketwire.com/mw/emailprcntct id=263235D22D0D6097 http://www2.marketwire.com/mw/emailprcntct id=1B734145463CA613

[ Back To Cisco News 's Homepage ]







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.